EpiCept Reports Fourth Quarter and Full Year 2012 Operating and Financial Results
28 févr. 2013 00h12 HE
|
Immune Pharmaceuticals Inc
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory
News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) today
announced operating and financial results...
EpiCept Reports Fourth Quarter and Full Year 2012 Operating and Financial Results
28 févr. 2013 00h10 HE
|
Immune Pharmaceuticals Inc
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory
News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) today
announced operating and financial results...
Immune Initiates Bertilimumab Phase II Clinical Trial in Ulcerative Colitis
21 févr. 2013 00h17 HE
|
Immune Pharmaceuticals Inc
Bertilimumab Targets Eotaxin-1, a Chemokine Over-Expressed in Ulcerative Colitis
Patients
and executive officers of EpiCept is also included in EpiCept's registration
statement Post-Effective...
EpiCept Corporation and Immune Pharmaceuticals Amend Merger Agreement
12 févr. 2013 00h01 HE
|
Immune Pharmaceuticals Inc
IMMUNE TO PROVIDE EPICEPT WITH UP TO $0.5 MILLION IN WORKING CAPITAL
HERZLIYA-PITUACH, Israel & TARRYTOWN, N.Y.--(BUSINESS
WIRE (http://www.businesswire.com/))-- Regulatory News:
Immune...
EpiCept Corporation to Present at the 15th BIO CEO & Investor Conference
06 févr. 2013 19h02 HE
|
Immune Pharmaceuticals Inc
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory
News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced
today that Robert W. Cook, Interim...
EpiCept Reports Total Shares Outstanding
31 janv. 2013 17h08 HE
|
Immune Pharmaceuticals Inc
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory
News:
Pursuant to the requirements of the Swedish Financial Supervisory Authority,
EpiCept Corporation (“EpiCept”) (NASDAQ...
Daniel Teper of Immune Pharmaceuticals to Present at the 6th Annual OneMedForum
09 janv. 2013 17h01 HE
|
Immune Pharmaceuticals Inc
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory
News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced
today that Daniel Teper, Chief...
EpiCept Reports Third Quarter 2012 Operating and Financial Results
14 nov. 2012 00h06 HE
|
Immune Pharmaceuticals Inc
Conference Call Begins at 9:00 A.M. Eastern Time Today
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory
News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX:...
EpiCept to Report Third Quarter 2012 Operating and Financial Results on November 14, 2012
12 nov. 2012 00h01 HE
|
Immune Pharmaceuticals Inc
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory
News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced
today that it will host a conference...
Immune Pharmaceuticals and EpiCept Corporation Agree to Merge
08 nov. 2012 00h01 HE
|
Immune Pharmaceuticals Inc
HERZLIYA-PITUACH, Israel & TARRYTOWN, N.Y.--(BUSINESS
WIRE (http://www.businesswire.com/))-- Regulatory News:
Immune Pharmaceuticals Ltd. (“Immune”), a privately held Israeli company, and
EpiCept...